Month: April 2020

As spring allergy season sets in, allergy and asthma sufferers may be concerned that continuing their normal use of inhaled and intranasal corticosteroids may not be advisable during the pandemic. However, it is more important than ever for these patients to keep...

Attention: Midwest Allergy asthma patients Recent data indicates that COVID-19 can persist in droplets in the air for 1 to 2 hours after nebulized therapies.  We are recommending that patients minimize use of nebulized therapies if possible.  If nebulized therapies...